Food and Drug Administration (FDA) has issued a second approvable letter for bazedoxifene, a selective estrogen receptor modulator, for the prevention of postmenopausal osteoporosis.
苯卓昔芬是一种选择性雌激
调节剂，为预防绝经后骨质疏松症药物。
;;
,
;;;;Food and Drug Administration (FDA) has issued a second approvable letter for bazedoxifene, a selective estrogen receptor modulator, for the prevention of postmenopausal osteoporosis.
苯卓昔芬是一种选择性雌激调节剂，为预防绝经后骨质疏松症药物。
Hormone therapy and enous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
绝经后女性中激疗法与静脉血栓栓塞
相关性——雌激给药途径与孕激对其影响（ESTHER研究）
Title：Hormone therapy and enous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
绝经后女性中激疗法与静脉血栓栓塞相关性——雌激给药途径与孕激对其影响（ESTHER研究）
声明：以上例句、词性分类均由互联网资源自动生成，部分未经过人工审核，其表达内容亦不代表本软件观点；若发现问题，欢迎向我们指正。
